VicPlas International Ltd. AI Stock Analysis
Want to see SG:569 full AI Analyst Report?
VicPlas International Ltd. (569) AI Stock Analysis
VicPlas International Ltd.
(SGX:569)
The overall stock score of 38 reflects severe fundamental and technical weaknesses. The most significant factors are deeply deteriorating financial health, including collapsing margins and escalating cash burn, coupled with a highly unprofitable valuation. Persistent bearish technical trends further suppress the stock's near-term outlook.
VicPlas International Ltd. (569) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 31.69M
- Dividend Yield
- ―
- Average Volume (3M)
- 107.12K
- Price to Earnings (P/E)
- -6.2
- Beta (1Y)
- 0.62
- Revenue Growth
- 9.96%
- EPS Growth
- -119.57%
- Country
- Singapore
- Employees
- 1,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
VicPlas International Ltd. Business Overview & Revenue Model
Company Description
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Repub...
VicPlas International Ltd. Financial Statement Overview
Summary
Financial performance is severely compromised, characterized by a gross margin collapse from 55.1% to 12.3%, three consecutive years of widening net losses, and persistent negative free cash flow. Escalating debt and declining equity further elevate financial risk.
Income Statement
20Very NegativeBalance Sheet
35NegativeCash Flow
20Very Negative| Breakdown | TTM | Jul 2026 | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 127.30M | 127.30M | 120.81M | 102.39M | 129.22M | 130.81M |
| Gross Profit | 15.61M | 15.61M | 66.57M | 52.42M | 66.19M | 68.06M |
| EBITDA | 2.97M | 2.00M | 8.76M | 6.93M | 13.18M | 17.93M |
| Net Income | -5.14M | -5.14M | -2.36M | -1.36M | 4.24M | 8.84M |
Balance Sheet | ||||||
| Total Assets | 147.66M | 147.66M | 137.71M | 131.49M | 119.02M | 130.34M |
| Cash, Cash Equivalents and Short-Term Investments | 5.93M | 5.93M | 4.71M | 4.97M | 8.57M | 8.89M |
| Total Debt | 48.44M | 48.44M | 41.11M | 32.47M | 17.55M | 28.01M |
| Total Liabilities | 80.05M | 80.05M | 66.32M | 56.93M | 40.46M | 52.03M |
| Stockholders Equity | 67.62M | 67.62M | 71.39M | 74.57M | 78.56M | 78.31M |
Cash Flow | ||||||
| Free Cash Flow | -4.03M | -4.03M | -5.99M | -7.82M | 12.53M | -2.61M |
| Operating Cash Flow | 1.40M | 1.40M | 388.00K | 6.72M | 17.88M | 10.25M |
| Investing Cash Flow | -5.40M | -5.40M | -6.36M | -14.53M | -5.10M | -12.79M |
| Financing Cash Flow | 5.10M | 5.10M | 5.75M | 4.24M | -12.76M | 1.63M |
VicPlas International Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:569, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.07, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 24.80 is Positive, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:569.
VicPlas International Ltd. Peers Comparison
Overall Rating
SG:OTX74Outperform
SG:56938Underperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:569 | VicPlas International Ltd. | 0.06 | -0.03 | -32.61% | |
| SG:505 | Asiamedic Limited | 0.02 | -0.00 | -10.53% | |
| SG:546 | Medtecs International Corporation Ltd. | 0.10 | -0.03 | -22.13% | |
| SG:584 | AJJ Medtech Holdings Limited | 0.01 | 0.00 | 0.00% | |
| SG:MIJ | Alliance Healthcare Group Ltd. | 0.18 | 0.06 | 55.17% | |
| SG:OTX | Medinex Ltd. | 0.21 | -0.01 | -3.59% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 02, 2026
